Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine F Carpentier

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Radiology and Oncology|December 5, 2018
Nuclear magnetic resonance metabolic fingerprint of bevacizumab in mutant IDH1 glioma cellsTanja Mesti, Nadia Bouchemal, Claire Banissi, et al.
International Journal of Molecular Sciences|May 13, 2014
Rationale for the use of upfront whole brain irradiation in patients with brain metastases from breast cancerAgnes V Tallet, David Azria, Emilie Le Rhun, et al.
Journal for Immunotherapy of Cancer|August 5, 2020
Reintroduction of immune-checkpoint inhibitors after immune-related meningitis: a case series of melanoma patientsStefania Cuzzubbo, Pauline Tetu, Sarah Guegan, et al.
Journal for Immunotherapy of Cancer|September 24, 2024
Neurofilament light chain levels as an early predictive biomarker of neurotoxicity after CAR T-cell therapyMarion Larue, Amélie Bouvier, Alexis Maillard, et al.
Neurology|July 19, 2022
Long-term Neurologic Safety in Patients With B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T-Cell TherapyRenata Ursu, Didier Maillet, Catherine Belin, et al.
Annals of Neurology|April 1, 2003
Continuous growth of mean tumor diameter in a subset of grade II gliomasEmmanuel Mandonnet, Jean-Yves Delattre, Marie-Laure Tanguy, et al.
Plos One|July 10, 2015
IDH-Mutation Is a Weak Predictor of Long-Term Survival in Glioblastoma PatientsAymeric Amelot, Patricia De Cremoux, Véronique Quillien, et al.
Journal of Neuro-Oncology|February 22, 2015
Evolution of the Karnosky Performance Status throughout life in glioblastoma patientsAdama Sacko, Miao-Miao Hou, Michael Temgoua, et al.
Cancers|September 19, 2020
Impact of New Systemic Treatment and Radiotherapy in Melanoma Patients with Leptomeningeal MetastasesPauline Tétu, Lila Sirven-Villaros, Stefania Cuzzubbo, et al.
Neurosurgery|January 27, 2015
Initial experience using awake surgery for glioma: oncological, functional, and employment outcomes in a consecutive series of 25 casesEmmanuel Mandonnet, Philip De Witt Hamer, Isabelle Poisson, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Radiology and Oncology|December 5, 2018
Nuclear magnetic resonance metabolic fingerprint of bevacizumab in mutant IDH1 glioma cellsTanja Mesti, Nadia Bouchemal, Claire Banissi, et al.
International Journal of Molecular Sciences|May 13, 2014
Rationale for the use of upfront whole brain irradiation in patients with brain metastases from breast cancerAgnes V Tallet, David Azria, Emilie Le Rhun, et al.
Journal for Immunotherapy of Cancer|August 5, 2020
Reintroduction of immune-checkpoint inhibitors after immune-related meningitis: a case series of melanoma patientsStefania Cuzzubbo, Pauline Tetu, Sarah Guegan, et al.
Journal for Immunotherapy of Cancer|September 24, 2024
Neurofilament light chain levels as an early predictive biomarker of neurotoxicity after CAR T-cell therapyMarion Larue, Amélie Bouvier, Alexis Maillard, et al.
Neurology|July 19, 2022
Long-term Neurologic Safety in Patients With B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T-Cell TherapyRenata Ursu, Didier Maillet, Catherine Belin, et al.
Annals of Neurology|April 1, 2003
Continuous growth of mean tumor diameter in a subset of grade II gliomasEmmanuel Mandonnet, Jean-Yves Delattre, Marie-Laure Tanguy, et al.
Plos One|July 10, 2015
IDH-Mutation Is a Weak Predictor of Long-Term Survival in Glioblastoma PatientsAymeric Amelot, Patricia De Cremoux, Véronique Quillien, et al.
Journal of Neuro-Oncology|February 22, 2015
Evolution of the Karnosky Performance Status throughout life in glioblastoma patientsAdama Sacko, Miao-Miao Hou, Michael Temgoua, et al.
Cancers|September 19, 2020
Impact of New Systemic Treatment and Radiotherapy in Melanoma Patients with Leptomeningeal MetastasesPauline Tétu, Lila Sirven-Villaros, Stefania Cuzzubbo, et al.
Neurosurgery|January 27, 2015
Initial experience using awake surgery for glioma: oncological, functional, and employment outcomes in a consecutive series of 25 casesEmmanuel Mandonnet, Philip De Witt Hamer, Isabelle Poisson, et al.
Pageof 8